Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum

Area of Science:

• Molecular Biology
• Parasitology
• Genetics

Background:

• Malaria remains a significant global health challenge, causing widespread illness and death.
• There is an urgent need for innovative therapeutic and preventative strategies against malaria.
• Genetic manipulation of the malaria parasite, Plasmodium falciparum, is crucial for understanding its biology and developing interventions.

Purpose of the Study:

• To evaluate the efficacy of Streptococcus pyogenes Cas9 DNA endonuclease and single guide RNAs (sgRNAs) for genome editing in Plasmodium falciparum.
• To assess the efficiency of gene disruption for key Plasmodium falciparum genes using this CRISPR-Cas9 system.
• To establish a rapid method for generating genetically modified malaria parasites.

Main Methods:

• Utilized the CRISPR-Cas9 system with Streptococcus pyogenes Cas9 and T7 RNA polymerase-produced sgRNAs.
• Targeted essential genes within the Plasmodium falciparum genome, including the knob-associated histidine-rich protein (kahrp) and erythrocyte binding antigen 175 (eba-175) genes.
• Generated transgenic Plasmodium falciparum parasites to assess gene disruption frequencies.

Main Results:

• Achieved efficient editing of the Plasmodium falciparum genome using the Cas9-sgRNA system.
• Demonstrated high gene disruption frequencies (≥ 50-100%) for targeted genes.
• Successfully generated transgenic parasites within a standard timeframe, indicating the method's efficiency.

Conclusions:

• The Cas9-sgRNA system, produced with T7 RNA polymerase, is an effective tool for Plasmodium falciparum genome editing.
• This approach facilitates rapid and efficient gene disruption in malaria parasites.
• These findings provide a promising new avenue for developing novel malaria control strategies.